Efectividad de Tocilizumab en Pacientes COVID-19 Revisión Narrativa
dc.contributor.advisor | Campos Villalta, Karla Janet | es |
dc.contributor.advisor | Martínez Parada, Cristina Elizabeth | es |
dc.contributor.author | Bracety Torres, Mayra Alejandra | es |
dc.date.accessioned | 2023-12-14T21:38:49Z | |
dc.date.available | 2023-12-14T21:38:49Z | |
dc.date.issued | 2022-02-01 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14492/1830 | |
dc.language.iso | es_SV | |
dc.subject | Tocilizumab | |
dc.subject | covid-19 | |
dc.subject | interleucina-6 | |
dc.subject | citocinas | |
dc.subject.ddc | 615 | |
dc.title | Efectividad de Tocilizumab en Pacientes COVID-19 Revisión Narrativa | es |
dc.type | Thesis |
Files
Original bundle
1 - 1 of 1